• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>Matthew Coffina

Matthew Coffina

  1. All
  2. Videos
  3. Investing
  1. How Morningstar Values Stocks

    StockInvestor editor Matt Coffina breaks down how cash flow analyses, uncertainty ratings, and economic moats play key roles in our equity valuation methodology.

  2. Top Picks From Morningstar's Strategists

    Morningstar investment experts Russ Kinnel, Matt Coffina, Josh Peters, and Sam Lee answer viewer questions about the current market and the best opportunities in stocks, funds, and ETFs today.

  3. Sky Didn't Fall for UnitedHealth

    UnitedHealth stock has advanced as investors saw reform would not be as negative as anticipated, and there is still upside from here.

  4. How Will Supreme Court's Ruling Affect Health-Care Stocks?

    Regardless of when and how the justices rule on the Affordable Care Act as well as the best- and worst-case scenarios, company valuations should see little change, says Morningstar's Matt Coffina.

  5. Will a Medco/Express Scripts Merger Pass Regulatory Muster?

    Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.

  6. Is the U.S. Serious About Cutting Health-Care Costs?

    Read one professor's take, and join the discussion!

  7. Managed Care: How Likely Is a Worst-Case Scenario?

    Although a new public health-care plan could drastically cut MCOs' fair values, that legislation is likely not passable.

  8. How Will Health-Care Reform Impact These Funds?

    Some great funds see attractive opportunities in the health-care sector.

  9. The Market's Most Overvalued Stocks

    Fancy names can't make up for bad businesses.

  10. Our Take on the First Quarter

    The Fed steps into the storm; stagflation worries persist.

12
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.